ChabioTech Obtains Patent Rights for 'Stem Cell-Derived Skin Progenitor Cell Culture Medium'
[Asia Economy Reporter Kum Boryeong] Cha Biotech announced on the 8th that it has acquired a patent related to 'Stem Cell-Derived Skin Progenitor Cell Culture Medium and Its Manufacturing Method.'
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "This Strike Must Fail": Criticism Emerges Within Samsung as DS-MX Conflict Surfaces
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Cha Biotech stated, "With the safe and optimized culture medium produced through this invention, we plan to utilize it as a raw material for various products that can improve skin tissue damage such as anti-aging, burns, and stretch marks, aiming to enter overseas markets," and added, "We also plan to apply it in the development of pharmaceuticals such as exosome therapies based on the culture medium."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.